Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Paediatric Drugs|November 17, 2017
Agents in Development for Childhood Acute Lymphoblastic LeukemiaKelly W Maloney, Lia GoreJournal of Pediatric Hematology/Oncology|April 27, 2013
Pulmonary presentation of relapsed acute myeloid leukemiaLindsey M Hoffman, Lia Gore, Kelly W MaloneyPediatric Blood & Cancer|August 1, 2020
Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemiaAmanda C Winters, Kelly W Maloney, Amy L Treece, et al.Best Practice & Research. Clinical Haematology|December 14, 2022
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALLLia GoreBritish Journal of Haematology|September 22, 2011
Acute lymphoblastic leukaemia in children with Down syndrome: an updated reviewKelly W MaloneyExpert Opinion on Investigational Drugs|September 6, 2011
Entinostat for treatment of solid tumors and hematologic malignanciesJeffrey Knipstein, Lia GoreHematology. American Society of Hematology. Education Program|December 7, 2019
Moving immunotherapy into the front line in ALLAmanda Winters, Lia GoreFrontiers in Oncology|April 19, 2014
Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric ApplicationsLindsey M Hoffman, Lia GoreHaematologica|June 4, 2024
Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemiaKaylyn Utley Lyons, Lia GoreCell|March 29, 2024
Only the beginning: 50 years of progress toward curing childhood cancerLia Gore, Maureen M O'BrienPageof 16